Led Ridge Biotechnologies' oversubscribed $25M seed round — AI-enabled enzyme and precision drug design, incubated at SHV.
Ridge Biotechnologies is focused on AI-driven enzyme and targeted drug design to develop precision medicines
Ridge Biotechnologies is focused on AI-driven enzyme and targeted drug design to develop precision medicines. Their platform employs machine learning models and high-throughput cell-free experimentation to create therapeutics with enhanced specificity and reduced off-target effects.